Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015524
Filing Date
2024-11-13
Accepted
2024-11-13 16:10:52
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240930x10q.htm   iXBRL 10-Q 1805015
2 EX-10.2 tmb-20240930xex10d2.htm EX-10.2 28700
3 EX-31.1 tmb-20240930xex31d1.htm EX-31.1 14526
4 EX-31.2 tmb-20240930xex31d2.htm EX-31.2 14564
5 EX-32.1 tmb-20240930xex32d1.htm EX-32.1 7801
6 EX-32.2 tmb-20240930xex32d2.htm EX-32.2 7869
  Complete submission text file 0001558370-24-015524.txt   6669572

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20240930.xsd EX-101.SCH 49794
8 EX-101.CAL tmb-20240930_cal.xml EX-101.CAL 48819
9 EX-101.DEF tmb-20240930_def.xml EX-101.DEF 188396
10 EX-101.LAB tmb-20240930_lab.xml EX-101.LAB 397768
11 EX-101.PRE tmb-20240930_pre.xml EX-101.PRE 333337
81 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240930x10q_htm.xml XML 876103
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 241454284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)